Actively Recruiting
Feasibility Study of a Culturally Adapted Problem-Solving Therapy for Postnatal Women with Suicidal Thoughts in Pakistan
Led by Pakistan Institute of Living and Learning · Updated on 2024-08-12
90
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the feasibility and acceptability of a culturally adapted Manual-Assisted Problem-Solving Intervention CMAP-SI for women experiencing suicidal thoughts during the postnatal period. The study focuses on women aged 16 to 44 years in Pakistan, aiming to adapt the CMAP intervention to the local cultural context and evaluate its potential to reduce suicidal ideation in this vulnerable group. Participants receiving the CMAP-SI intervention will engage in a brief problem-solving therapy based on cognitive behavioral therapy principles. The therapy involves 4 weekly sessions followed by 4 sessions every two weeks, each lasting about 50 minutes. The intervention has been culturally tailored with Urdu translations and case scenarios relevant to Pakistani culture, addressing issues such as gender roles, family conflicts, and financial difficulties. The study also includes a comparison group receiving treatment as usual by their primary care physicians. During the study, women will be assessed at baseline and again at 3 months for feasibility and acceptability of the intervention, as well as changes in suicidal ideation, depression, social support, life events, and quality of life. Various validated scales like the Beck Scale for Suicidal Ideation and Edinburgh Postnatal Depression Scale will be used. Researchers will also collect data on any suicide attempts or self-harm incidents. Safety protocols include recording participants primary care contacts and treatment details. The total study duration for each participant is at least 3 months from baseline assessment.
CONDITIONS
Brief Title
A Problem-Solving Intervention for Women With Suicidal Ideation During Postnatal Period in Pakistan
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Mothers aged 16 to 44 years with children 0 to 30 months old
- Residents of the study area
- Able to provide informed consent
- Presenting with suicidal ideation as measured by the Beck Suicidal Ideation Scale (score 1 or 2 on items 4 and 5)
- Not requiring inpatient psychiatric treatment
You will not qualify if you...
- Mothers with any physical or psychiatric condition severe enough to prevent study participation
Research Team
T
Tayyaba Kiran, PhD.
R
Rabia Sattar, PhD. Cont.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here